{"id":"W2340320857","doi":"10.1097/ico.0000000000000803","title":"Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease","year":2016,"lang":"en","type":"article","venue":"Cornea","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Omeros Corporation; Valeant Pharmaceuticals International","keywords":"Medicine; Placebo; Discontinuation; Intraocular pressure; Adverse effect; Visual acuity; Ophthalmology; Tolerability; Dysgeusia; Population; Artificial tears; Anesthesia; Surgery; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001045143,0.0003280531,0.0009641497,0.0002496123,0.0001612336,0.0003522838,0.0002717219,0.0006021968,0.00156416],"category_scores_gemma":[0.00128228,0.0001504824,0.0006649133,0.0001924026,0.0001882336,0.0002533949,0.0001298278,0.0006657341,0.0002465547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002626577,"about_ca_system_score_gemma":0.000393278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003043114,"about_ca_topic_score_gemma":0.0005851134,"domain_scores_codex":[0.9995151,0.0002198439,0.00005294571,0.00006214871,0.0001017738,0.00004832264],"domain_scores_gemma":[0.9992154,0.0002087098,0.0004204503,0.0000230501,0.00005252273,0.00007988965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.554498,0.009070695,0.03954675,0.004679279,0.001828903,0.0003449507,0.0002365459,0.0008010569,0.0670102,0.0001502272,0.002033689,0.3197997],"study_design_scores_gemma":[0.2312628,0.623006,0.1191093,0.0005194643,0.00221668,0.001126388,0.0001775352,0.001739214,0.01354296,0.0001588176,0.007093609,0.00004731757],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747843,0.02317854,0.0003355723,0.0002594308,0.00006700896,0.0002850605,0.0002218737,0.0000472481,0.0008208306],"genre_scores_gemma":[0.9948343,0.003305286,0.0005633591,0.0004195076,0.0001035376,0.0001681416,0.0002148467,0.000004940566,0.0003859767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00156416,"threshold_uncertainty_score":0.005527258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007535532079675399,"score_gpt":0.2216866028418226,"score_spread":0.2141510707621472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}